News
Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.
The Chosun Ilbo on MSN10h
Trump drug pricing order opens doors for Korean biosimilarsA sweeping executive order signed by U.S. President Donald Trump to slash domestic drug prices has drawn fierce opposition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback